These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4146701)

  • 61. The effects of ICI 50172, propranolol, pronethalol and MJ 1999 on beta-receptors.
    Wale J; Pun LQ; Rand MJ
    Eur J Pharmacol; 1969 Oct; 8(1):25-35. PubMed ID: 4391044
    [No Abstract]   [Full Text] [Related]  

  • 62. Cardiac electrophysiological effects of medroxalol in anesthetized dogs.
    Weissenburger J; Heckle J; Juliard JM; Jaillon P; Haegele K; Cheymol G
    J Cardiovasc Pharmacol; 1983; 5(3):462-7. PubMed ID: 6191148
    [No Abstract]   [Full Text] [Related]  

  • 63. Blockade of cardiac effects of isoproterenol by the stereoisomers of sotalol.
    Somani P; Bachand T
    Eur J Pharmacol; 1969 Sep; 7(3):239-47. PubMed ID: 4390869
    [No Abstract]   [Full Text] [Related]  

  • 64. Pharmacological evaluation of new alkylesters of 4-[(2-hydroxy-3-alkylamino)propoxy]phenylcarbamic acids with beta-adrenolytic properties.
    Racanská E; Csöllei J; Svec P
    Pharmazie; 1990 Nov; 45(11):851-3. PubMed ID: 1983125
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The development of beta adrenergic blocking drugs: a retrospective and prospective evaluation.
    Moran NC
    Ann N Y Acad Sci; 1967 Feb; 139(3):649-60. PubMed ID: 4382726
    [No Abstract]   [Full Text] [Related]  

  • 66. [Effects of adrenaline derivatives on the heart-lung preparation of the dog].
    Mima T; Yamada S
    Nihon Yakurigaku Zasshi; 1974 Mar; 70(2):251-60. PubMed ID: 4152671
    [No Abstract]   [Full Text] [Related]  

  • 67. Assessment of orciprenaline and isoproterenol infusions in asthmatic patients.
    McEvoy JD; Vall-Spinosa A; Paterson JW
    Am Rev Respir Dis; 1973 Sep; 108(3):490-500. PubMed ID: 4745246
    [No Abstract]   [Full Text] [Related]  

  • 68. beta-Adrenoceptor blocking activity of halogenated thienylethanolamine derivatives.
    Conde S; Corral C; Madroñero R; Alvarez-Insúa AS; Fernámdez-Tomé MP; Río J; Santos M
    J Med Chem; 1977 Jul; 20(7):970-4. PubMed ID: 17752
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Experience with a Doppler technique to investigate the interaction of isoprenaline and various B-adrenoceptor blocking drugs on blood vessels in the lower limb.
    FitzGerald DE; Harry JD
    Eur J Clin Pharmacol; 1985; 29(4):447-54. PubMed ID: 2868901
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The assessment of beta-adrenoceptor blocking drugs in man.
    McDevitt DG
    Br J Clin Pharmacol; 1977 Aug; 4(4):413-25. PubMed ID: 20123
    [No Abstract]   [Full Text] [Related]  

  • 71. Intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs at cardiac and vascular beta-adrenoceptors.
    Hamilton TC; Chapman V
    Life Sci; 1978 Aug; 23(8):813-9. PubMed ID: 30012
    [No Abstract]   [Full Text] [Related]  

  • 72. beta- and alpha-Adrenoceptor antagonism by medroxalol in healthy volunteers: relationship to dose and plasma concentration.
    Jaillon P; Weissenburger J; Biour M; Cheymol G; Haegele K; Schechter PJ; Koch-Weser J
    J Cardiovasc Pharmacol; 1982; 4(5):705-13. PubMed ID: 6182399
    [No Abstract]   [Full Text] [Related]  

  • 73. Beta-adrenergic blocking property of l-3-methoxy-omega-(1-hydroxy-1-phenylisopropylamino)-propiophenone-HCL (D 563) in femoral circulation.
    Sakai K
    Jpn J Pharmacol; 1970 Jun; 20(2):306-7. PubMed ID: 4393950
    [No Abstract]   [Full Text] [Related]  

  • 74. beta-Adrenergic blocking agents with acute antihypertensive activity.
    Baldwin JJ; Engelhardt EL; Hirschmann R; Lundell GF; Ponticello GS; Ludden CT; Sweet CS; Scriabine A; Share NN; Hall R
    J Med Chem; 1979 Jun; 22(6):687-94. PubMed ID: 37337
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Stimulation of H fields of Forel decreases total lung resistance in dogs.
    McCallister LW; Connelly JC; Kaufman MP
    J Appl Physiol (1985); 1988 Nov; 65(5):2156-63. PubMed ID: 3209559
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of some properties of pronethalol and propranolol. 1965.
    Black JW; Duncan WA; Shanks RG
    Br J Pharmacol; 1997 Feb; 120(4 Suppl):285-99; discussion 283-4. PubMed ID: 9142411
    [No Abstract]   [Full Text] [Related]  

  • 77. Dose-related effects of fenoterol and ritodrine in 10 peripheral vascular beds of the anesthetized dog.
    Reuwer PJ; Gerritse R; Charbon GA; Haspels AA
    J Cardiovasc Pharmacol; 1983; 5(2):329-34. PubMed ID: 6188911
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Proceedings: Non-specific cardiodepressant effects and hydrophobicity of two series of beta-adrenergic blocking drugs: influence of ring-alkylation and of n-alkylation.
    Hellenbrecht D; Grobecker H
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R31. PubMed ID: 4152361
    [No Abstract]   [Full Text] [Related]  

  • 79. Relationship between pharmacokinetic and pharmacodynamic behaviour of bufuralol and its metabolite Ro 3-7410 in hypertensive patients.
    Eckert M; Cocco G; Strozzi C; Heizmann P; Sfrisi C
    Eur J Clin Pharmacol; 1983; 24(4):479-84. PubMed ID: 6134625
    [No Abstract]   [Full Text] [Related]  

  • 80. Bronchopulmonary effects of caffeine in the anesthetized dog.
    Oskoui M; Aviado DM; Bellet S
    Respiration; 1970; 27(1):63-73. PubMed ID: 5517732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.